Latest Update | Premium Oncology Exporter – Trusted Worldwide
Afatinib 40mg Tablets are a targeted cancer therapy widely used in the treatment of specific types of non-small cell lung cancer (NSCLC). As demand rises globally for high-quality oncology medicines, Cordium Pharmaceuticals Pvt Ltd stands out as a reliable exporter from India, ensuring fast and secure delivery to major markets including the United States, Germany, United Kingdom, Netherlands, South Africa, United Arab Emirates, and Brazil.
What is Afatinib 40mg Tablet?
Afatinib is a tyrosine kinase inhibitor (TKI) that works by blocking signals that promote cancer cell growth. It is commonly prescribed for patients with EGFR mutation-positive non-small cell lung cancer (NSCLC).
Usage of Afatinib 40mg Tablets
Treatment of metastatic non-small cell lung cancer (NSCLC)
Effective in patients with EGFR mutations
Used as a first-line targeted therapy
Helps slow tumor growth and spread
Dosage Guidelines
Standard recommended dose: 40mg once daily
Taken on an empty stomach (at least 1 hour before or 2 hours after meals)
Dosage may be adjusted by a healthcare professional based on:
Patient tolerance
Side effects
Clinical response
⚠️ Always follow your doctor’s prescription strictly. Do not self-medicate.
Possible Side Effects
Like all medications, Afatinib may cause side effects. Common ones include:
Diarrhea
Skin rash or acne
Mouth sores
Nail infections
Dry skin
Decreased appetite
Serious side effects (rare):
Lung inflammation
Severe diarrhea leading to dehydration
Liver function abnormalities
👉 Immediate medical attention is advised if severe symptoms occur.
Why Choose Cordium Pharmaceuticals Pvt Ltd?
Trusted global exporter of oncology medicines
Assured quality and compliance standards
Competitive pricing for bulk and retail buyers
Fast international delivery across:
USA
Germany
UK
Netherlands
South Africa
UAE
Brazil
Reliable packaging and cold-chain logistics (if required)
Contact for Bulk Orders & Enquiries
📞 WhatsApp: +91-9405117673
📧 Email: info@cordiumpharma.com